Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
123
NCT00048464
T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant
Phase: Phase 1/2
Role: Lead Sponsor
Start: Oct 31, 2002
Completion: Not specified
NCT00058656
Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients
Start: Mar 31, 2003
NCT00078065
Xcellerated T CellsTM in Patients With Multiple Myeloma
Phase: Phase 2
Start: Nov 30, 2003
Completion: Jun 30, 2004
NCT00081783
Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients
Start: Mar 31, 2004